Cargando…
Real-World Use of Granulocyte-Colony Stimulating Factor in Patients with Breast Cancer from Alberta, Canada
SIMPLE SUMMARY: Most chemotherapy regimens used in the setting of non-metastatic breast cancer are myelosuppressive and are associated with toxicities with significant clinical implications, including febrile neutropenia. The use of granulocyte colony-stimulating factor (G-CSF) reduces the severity...
Autores principales: | Ding, Philip Q., Newcomer, Brandt J., Cheung, Winson Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777054/ https://www.ncbi.nlm.nih.gov/pubmed/36551681 http://dx.doi.org/10.3390/cancers14246197 |
Ejemplares similares
-
Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis
por: Rigo, Rodrigo, et al.
Publicado: (2021) -
Understanding Real-World Treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada
por: O’Sullivan, Dylan E., et al.
Publicado: (2023) -
Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada
por: Ding, Philip Q., et al.
Publicado: (2022) -
Prescription patterns of granulocyte colony–stimulating factors in patients with breast cancer: A real-world study
por: Hsu, Shu-Wei, et al.
Publicado: (2023) -
Granulocyte colony-stimulating factor and leukemogenesis.
por: de Figueiredo, Lorena Lobo, et al.
Publicado: (2004)